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 The World Health Organization (WHO) 
has made the general public to understand the 
transmission pattern of severe acute respiratory 
syndrome coronavirus-2 (SARS-CoV-2), which 
is responsible for COVID-19, across different 
countries of the world (1). There have been 
reports showing increase in confirmed COVID-
19 cases in low-and-middle–income countries 
(LMICs) such as Bangladesh, Cameroon, the 
Democratic Republic of Congo, India, Indonesia, 
Nigeria, Mali, Gambia, Senegal, Ghana, Sudan, 
Tunisia and other countries of Africa. However, 
the scientific communities have starred up 
various researches on COVID-19, in several 
areas including virus genomics and proteomics, 
epidemiology, pathogenesis, diagnostics, vacc- 
ines, drug discovery and therapy (including 
clinical trials) as well as preventive approaches 
to combat the pandemic. The scale and speed 
at which these COVID-19 researches are being 




conducted in other countries is unprecedented 
whereas this is very low in African countries 
when compared to these other countries in 
terms of funding. 
 There is the urgent need for various 
international organizations, African health insti- 
tutions, governments of African countries, priv- 
ate co-operations, and African philanthropists to 
come up with specific road maps for provision of 
funds for African scientists to conduct research 
on COVID-19 in such areas as basic research on 
SARS-CoV evolution and history, pathogenesis, 
transmission characteristics and disease model- 
ling in the population, diagnostics, outbreak res- 
ponse and prevention, drug and vaccine deve- 
lopment and clinical trials in different popu- 
lations because of the heterogeneity of the 
African population.   
 According to the Frontiers Coronavirus 
Funding Monitor, there were little or no calls for 
COVID-19 research funding for African scien- 
tists either by the African governments or pri- 
vate institutions and organizations (2). There 
were calls for or from Finland, India, Belgium, 
Austria, Germany, USA, Denmark, Canada and 
Global. Still African scientists will have to com- 
pete with scientists from these developed coun- 
tries, which will significantly reduce their chan- 
ces of obtaining these funds.   
 As a result of the increasing spread of 
the virus and severity of the disease, COVID-19 
pandemic is a serious public health emergency, 
and urgent steps should be taken in answering 
questions associated with the virus pandemic in 
Africa. Because of the weak economy, inade- 
quate health infrastructures and ineffective 
policies of most African countries, it is impera- 
tive to strengthen the Africa research capacity 
by coordinated and collaborative efforts within 
and outside the continent, to effectively combat 
emerging and re-emerging virus infections. This 
is the basis for the clarion call for funding of 
African scientists to meet the peculiar need of 
the continent with respect to the COVID-19 
pandemic.    
 In many ways, COVID-19 research 
funding requires multilateral collaborations and 
approaches to scale up the win to develop the 
vaccines and drugs that will have more comp- 
rehensive coverage considering the science of 
human genetics. The GDP of African countries is 
projected to fall by 5-8% due to this pandemic 
with prediction of 90-200 billion dollars loss (3), 
which is going to make funding of research 
difficult for governments of African countries. 
Therefore, multinational bodies such as Bill and 
Melinda Gates Foundation, National Institute of 
Health (NIH), Medical Research Council (MRC) 
UK, Wellcome Trust, Canadian Institutes of 
Health Research (CIHR) and other public or 
philanthropic funders of health research as high-
lighted by Viergever and Hendriks (4) should 
come to the aid of African scientists in fighting 
this global pandemic through provision of grants 
that will help in funding of COVID-19 research 
enumerated above as well as in human capacity 
building. Africa must not be left behind in 
proffering solutions to the challenges of COVID-
19 and to other potential pandemic infectious 
diseases peculiar to the continent. 
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